Agilent Technologies shares rose 1.6% this afternoon to a price of $147.48. The stock is still trading within range of its average target price of $145.5, and over the last 52 weeks, it has recorded a 9.6% performance. Analysts have given the Large-Cap Biotechnology stock target prices ranging from $125.0 to $165.0 dollars per share, with an average rating of buy.
Agilent Technologies's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.1%. The stock's short ratio is 1.74. The company's insiders own 0.28% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 91.7%. In conclusion, we believe there is mixed market sentiment regarding Agilent Technologies.
Institutions Invested in Agilent Technologies
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-12-31 | Blackrock Inc. | 9% | 27,257,939 | $4,020,000,727 |
| 2023-12-31 | Vanguard Group Inc | 9% | 25,279,117 | $3,728,164,067 |
| 2023-12-31 | Massachusetts Financial Services Co. | 5% | 13,246,489 | $1,953,592,141 |
| 2023-12-31 | State Street Corporation | 4% | 12,634,456 | $1,863,329,516 |
| 2023-12-31 | T. Rowe Price Investment Management, Inc. | 3% | 10,154,406 | $1,497,571,753 |
| 2023-12-31 | Wellington Management Group, LLP | 3% | 9,883,132 | $1,457,564,265 |
| 2023-12-31 | Price (T.Rowe) Associates Inc | 3% | 7,499,128 | $1,105,971,365 |
| 2023-12-31 | Geode Capital Management, LLC | 2% | 6,604,203 | $973,987,830 |
| 2023-12-31 | Pictet Asset Management Holding SA | 2% | 6,395,420 | $943,196,514 |
| 2023-12-31 | Morgan Stanley | 2% | 4,501,663 | $663,905,240 |
